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Hypothyroidism	in	humans	is	characterized	by	severe	neurological	consequences	that	are	often	irreversible,	
highlighting	the	critical	role	of	thyroid	hormone	(TH)	in	the	brain.	Despite	this,	not	much	is	known	about	
the	signaling	pathways	that	control	TH	action	in	the	brain.	What	is	known	is	that	the	prohormone	thyroxine	
(T4)	is	converted	to	the	active	hormone	triiodothyronine	(T3)	by	type	2	deiodinase	(D2)	and	that	this	occurs	in	
astrocytes,	while	TH	receptors	and	type	3	deiodinase	(D3),	which	inactivates	T3,	are	found	in	adjacent	neurons.	
Here,	we	modeled	TH	action	in	the	brain	using	an	in	vitro	coculture	system	of	D2-expressing	H4	human	glioma	
cells	and	D3-expressing	SK-N-AS	human	neuroblastoma	cells.	We	found	that	glial	cell	D2	activity	resulted	in	
increased	T3	production,	which	acted	in	a	paracrine	fashion	to	induce	T3-responsive	genes,	including	ecto-
nucleotide	pyrophosphatase/phosphodiesterase	2	(ENPP2),	in	the	cocultured	neurons.	D3	activity	in	the	neu-
rons	modulated	these	effects.	Furthermore,	this	paracrine	pathway	was	regulated	by	signals	such	as	hypoxia,	
hedgehog	signaling,	and	LPS-induced	inflammation,	as	evidenced	both	in	the	in	vitro	coculture	system	and	
in	in	vivo	rat	models	of	brain	ischemia	and	mouse	models	of	inflammation.	This	study	therefore	presents	
what	we	believe	to	be	the	first	direct	evidence	for	a	paracrine	loop	linking	glial	D2	activity	to	TH	receptors	in	
neurons,	thereby	identifying	deiodinases	as	potential	control	points	for	the	regulation	of	TH	signaling	in	the	
brain	during	health	and	disease.
Introduction
One of the most devastating aspects of neonatal hypothyroid-
ism is severe neurologic impairment and mental retardation, 
frequently associated with abnormal facies, deaf mutism, and 
motor spasticity (1, 2). These features are by and large irrevers-
ible, and a worldwide network of neonatal screening was put in 
place several decades ago to identify and treat the newborns with 
this condition. The adult brain is also sensitive to thyroid hor-
mone (TH). Hypothyroid patients are frequently lethargic, have 
poor motor coordination, memory impairment, and a tendency 
toward depression and mood disorders. In turn, hyperthyroidism 
is associated with irritability, anxiety, and mood swings (3), and 
the efficacy of antidepressive agents is potentiated when associ-
ated with TH administration.
While these syndromes illustrate a critical role played by TH 
in brain, not much is known about the signaling pathways that 
control TH action in this organ. In contrast with the majority of 
tissues, most TH in the brain is produced locally through activa-
tion of thyroxine (T4) to 3,5,3′-triiodothyronine (T3) via the action 
of the type 2 deiodinase (D2) (4). This has been studied directly 
through dual-labeling techniques and recently confirmed with the 
observation that mice with targeted disruption of the DIO2 gene 
exhibit half as much T3 in their brains as WT littermates (5). Thus, 
it is widely accepted that D2 expression in discrete areas of the 
brain increases TH signaling, a mechanism that has been linked 
to important brain functions such as cochlear development, the 
thyrotropin-releasing hormone/thyroid-stimulating hormone 
(TRH/TSH) feedback mechanism, and seasonal breeding in birds 
(6, 7). At the same time, the TH-inactivating type 3 deiodinase 
(D3) pathway is also active in discrete areas of the brain, damp-
ening TH action. Not surprisingly, the D2 and D3 pathways are 
inversely synchronized in a spatial and temporal fashion. Thus, 
it is assumed that the balance of these 2 pathways, i.e., D2 versus 
D3, and the less significant contribution of plasma T3, determine 
critical brain processes such as myelination, neuronal migration, 
glial differentiation, and neurogenesis (1, 8, 9).
Neurons express TH receptors (TRs) and are presumably the 
major target of T3 in the brain, but D2 is expressed in astrocytes, 
not neurons. This poses an anatomical question: does T3 gener-
ated in astrocytes reach TRs in neurons (2, 10, 11)? Furthermore, 
does the expression of D3 in the neurons limit this paracrine path-
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way? Such a paracrine mechanism became more plausible with 
the discovery of active TH transport into neurons via transporters 
such as monocarboxylate TH transporter-8 (MCT8): mutations in 
MCT8 explain the molecular basis for the Allan-Herndon-Dud-
ley syndrome (AHDS), a rare X-linked disorder characterized by 
neurological abnormalities including global developmental delay, 
central hypotonia, rotatory nystagmus, impaired hearing, and 
spasticity (12, 13). Another line of evidence supporting the con-
cept of paracrine TH transport in the brain stems from studies 
of TH metabolism in the hypothalamus, where D2 is expressed 
in specialized glial cells located in the floor and infralateral wall 
of the third ventricle in the mediobasal hypothalamus (MBH) 
called tanycytes (14, 15). It has been suggested that T3 generation 
via D2 in tanycytes could affect gene expression in TRH neurons, 
located in the paraventricular nucleus (PVN), thus explaining why 
T4 is critical in the negative feedback of TRH (16). At the same 
time, upregulation of D2 in tanycytes has been demonstrated in a 
rodent model for nonthyroidal illness and fasting, suggesting that 
a relative local increase in TH action mediates the central hypothy-
roidism frequently observed under these circumstances (17–19). 
In the Japanese quail, the expression of D2 in the MBH is induced 
by light. Intracerebroventricular administration of T3 mimics the 
photoperiodic response, whereas the D2 inhibitor iopanoic acid 
prevents gonadal growth, indicating that light-induced D2 expres-
sion in the medial basal hypothalamus (MBH) may be involved in 
the photoperiodic response of gonads in Japanese quail (7).
If this glial-D2/neuronal TR connection indeed exists, it could 
have the advantage of allowing for a much more sophisticated reg-
ulation of TH action in the brain, with control of glial or neuronal 
deiodination being a control point. A number of signaling path-
ways that have recently been established to be relevant for deiodin-
ases could be operant in the brain, for example, HIF-1α activation 
of D3 in hypoxic tissue (20) and hedgehog protein family–medi-
ated inactivation of D2 and activation of D3 (21, 22).
Direct evidence of a deiodinase-mediated transcriptional T3 
footprint in neurons has not been available. Here we modeled this 
pathway in vitro by coculturing D2-expressing H4 glioma cells 
with neuronal cells that express D3, SK-N-AS. Using this system, 
we found that glial cell–generated T3 (via D2 activity) was able to 
act in a paracrine fashion to induce the expression of T3-responsive 
genes in cocultured neurons, in spite of the presence of D3 activ-
ity. Furthermore, we found that the system is regulated by signals 
including hypoxia, hedgehog proteins, and LPS-induced inflamma-
tion. In vivo studies using ischemia and LPS further validate the 
relevance of these findings. To our knowledge, these data represent 
the first direct evidence for a paracrine loop linking D2 in glial cells 
to TRs in neurons, identifying deiodinases as control points for the 
regulation of TH signaling in the brain during health and disease.
Results
H4 and SK-N-AS cells mimic pattern of deiodinase expression found in vivo 
in the brain. In order to develop an in vitro model of TH metabolism 
and action in the brain, we first sought to identify suitable cell 
lines that would mimic the pattern of deiodinase expression in the 
brain, namely D2 expression in glial cells (14) and D3 in neurons 
(23). To that effect, glial-restricted precursor cells were differenti-
ated in the presence of T3, PDGF-el, bFGF, or FCS (24), but D2 
expression could not be induced in these cells (data not shown). At 
the same time, the screening of several glioma and microglia cell 
lines identified the human H4 glioma cells (Figure 1A) that exhibit 
substantial D2 activity but not type 1 deiodinase (D1) or D3 (Fig-
ure 1B). Just as in primary astrocytes (data not shown), H4 cells 
also express other key components of TH transport (monocarbox-
ylic acid transporter 8 [MCT8], MCT10, and solute carrier organic 
anion transporter 1c1 [SLCO1C1; also known as OATP14]) and 
action (TRα, TRβ, neurogranin [NRGN; also known as RC3], and 
ectonucleotide pyrophosphatase/phosphodiesterase 2 [ENPP2]) in 
the brain (Figure 1C). As part of this model, we chose to use the 
SK-N-AS neuroblastoma cell line, which has D3 activity as previ-
ously characterized (Figure 1, A and B) (20). The TH transporters 
MCT8 and MCT10 were found to be expressed similarly in both cell 
lines, whereas the expression of OATP14 transporter tended to be 
higher in the neuroblastoma cells (Figure 1C).
Subsequently, we tested to determine whether these cell lines 
are responsive to T3 by incubating both lines in media containing 
charcoal-stripped serum or 100 nM T3 (Figure 1D). We looked at 2 
previously characterized T3-responsive genes in the brain, i.e., RC3 
and ENPP2 (2), having found that only SK-N-AS cells consistently 
respond to T3 in a concentration- and time-dependent fashion, 
increasing ENPP2 expression to a maximum of approximately 
5-fold (Figure 1, D–F). In contrast, glial cells did not respond to 
T3 at all when these same genes were tested (Figure 1, D–F). As 
uncoupling protein 2 (UCP2) gene expression did not change with 
the addition of T3 in the media of either cell type (Figure 1D), this 
gene was subsequently used as control.
Coculture of neuronal and glial cells is required for sensitivity to T4. To 
test the hypothesis that glial-derived T3 acts in neuronal cells, we 
took advantage of an in vitro setup designed for coculture of cells 
in 2 adjacent compartments that are bathed with the same culture 
media (Transwell System; Figure 1E). Using this setup, we first 
incubated both cell types with T3, having found that ENPP2 gene 
expression is stimulated in SK-N-AS cells regardless of whether 
these cells are cultured alone or with H4 cells; as always, the latter 
did not respond to exposure to T3 (Figure 1, F and G). In the next 
set of experiments, we chose to incubate all cells with T4 in media 
containing 0.1% BSA (instead of FBS), so that the free concentra-
tion of T4 could be defined as described previously (25). Under 
these conditions, H4 and/or SK-N-AS cells were exposed to 20 pM 
free T4 (similar to free T4 concentration in human serum) for 
48 hours. While approximately 2-fold induction of ENPP2 gene 
expression was observed in SK-N-AS cells grown alone, coincuba-
tion with H4 cells magnified the T4-induced ENPP2 gene expres-
sion by approximately 7-fold (Figure 2A). The effect of T4 on 
ENPP2 gene expression followed a dose-response pattern, with pro-
portional increments observed in the range between 0 and 48 pM 
(data not shown). In contrast, cell coincubation did not affect 
ENPP2 gene expression in SK-N-AS cells when T4 was not added to 
the media, and UCP2 gene expression remained stable throughout 
the experiment (Figure 2A). To determine whether cell coincuba-
tion could be affecting the fractional conversion of T4 to T3, and 
hence T3 production, the latter was monitored by periodic sam-
pling of the media followed by separation and quantification of 
iodothyronines by UPLC as described (26). The conversion of T4 
to T3 increased steadily only when the H4 cells were used, and this 
was not affected by coincubation with SK-N-AS cells (Figure 2B). 
The complete analysis of TH metabolism using different radioac-
tive substrates confirmed that H4 cells metabolize T4 into T3 and 
iodide via D2 (Figure 2C), SK-N-AS cells further metabolize T3 
into T2 and T1 via D3 (Figure 2D), and the coculture of H4 and 
SK-N-AS produces T3 and its expected metabolites (Figure 2E).
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Figure 1
TH signaling in neuronal (SK-N-AS) and glial (H4) cell lines. (A) Immunocytochemistry of SK-N-AS and H4 probed with α-tubulin and stained with 
DAPI. Original magnification, ×20. (B) Endogenous deiodinase activity in H4 and SK-N-AS (SK) cell lines. nd, not detectable. (C) RNA expression 
pattern of genes involved in TH metabolism and action as determined by quantitative RT-PCR in H4 and SK-N-AS cell lines. (D) Responsiveness 
of putative T3-target genes (UCP2, RC3, and ENPP2) in H4 and SK-N-AS cell lines treated with media containing charcoal-stripped serum or 
100 nM T3 for 48 hours as indicated. 5× indicates 5-fold induction of expression. (E) Schematic representation of the Transwell System in which 
an insert is placed on a 6-well plate and cells (H4) are seeded inside the insert; SK-N-AS cells are seeded at the bottom of the 6-well plate. After 
cells are seeded, both cell types are kept separated overnight and then placed together in the same multiwell plate as indicated. (F) Dose respon-
siveness of ENPP2 gene to T3 in H4 and SK-N-AS cell lines incubated alone as in D or coincubated in the Transwell system for 48 hours as indi-
cated. (G) Same as in F, except that this is a time-responsiveness to T3. In all experiments, values are mean ± SEM of 5–9 independent wells; 
*P < 0.01 versus control.
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To verify that T4-induced ENPP2 gene expression in SK-N-AS 
cells is due to D2-mediated T3 production in H4 cells, we repeated 
these coculture studies in the presence of 20 nM 3,5′,3′ triiodothy-
ronine (rT3), an inert iodothyronine that competitively inhibits D2 
(27). While the incubation with increasing concentrations of T4 
progressively increased ENPP2 gene expression in SK-A-AS cells, 
the same was not observed when rT3 was added to the media (Fig-
ure 2F). As a control, rT3 did not interfere with the ENPP2 induc-
tion when 20 nM T3 was added to the media (Figure 2F). Greater 
than 95% inhibition of D2 was verified at the end of the incubation 
period by assaying D2 activity in cell sonicates (data not shown). 
Next, to prove that T3 is the mediator of ENPP2 gene expression 
by T4, we repeated these studies in the presence of a high-affinity 
α-T3 rabbit antiserum, previously shown to immunoneutralize T3 
Figure 2
H4 astrocyte cells activate T4 into T3 and establish a mRNA footprint in neuronal SK-N-AS cells. (A) Effects of T4 addition on ENPP2 or UCP2 
gene expression in cultures of SK-N-AS or cocultures of SK-N-AS and H4 cells as indicated. Cells were cultured as in legend to Figure 1 and 
treated with 20 pM T4 (free fraction) for 48 hours. (B) Fractional conversion of T4 to T3 as measured after addition of 125I-T4 and determination 
of outer ring deiodination via measurement of free 125I. Media samples were collected at the indicated times. (C) Chromatograms of H4 cell 
medium at the indicated times after addition of 125I-T4. Typical peaks of 125-T3 and 125I are shown after 24 hours. (D) Same as in C, except 
that 125I-T3 was added to cultures of SK-N-AS cells and 125I-T2 and 125I-T1 peaks are visualized. (E) Same as in C, except that 125I-T4 was 
added to H4 and SK-N-AS cocultures and the indicated peaks are visualized. (F) Same as in A, except that different concentrations of free T4 
were used and 20 nM rT3 was added at the beginning of incubation as indicated. T3 indicates that 100 nM T3 was added at the beginning of 
incubation. (G) Same as in F, except that α-T3 antiserum was added at time zero as indicated. In all experiments, values are mean ± SEM of 
5–9 independent wells; *P < 0.01 versus control.
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in cell media (26). Remarkably, addition of the α-T3 antiserum sig-
nificantly blunted the ENPP2 response to T4 (Figure 2G), without 
affecting the fractional conversion of T4 to T3 (data not shown).
Hypoxia and hedgehog pathway decrease the astrocyte-mediated 
neuronal transcriptional T3 footprint in a model of brain stroke. Once we 
determined that T3 production by glial cells (H4) defines a specific 
transcriptional footprint in neuronal cells (SK-N-AS), we sought 
to verify whether programmed changes in deiodinase activity that 
were triggered by physiologically and/or pathophysiologically 
relevant pathways in the brain could affect this mechanism. A 
stroke model was tested, given that ischemia and hypoxia induce 
D3 expression via an HIF-1α–mediated mechanism in postinfarc-
tion myocardium and during hypertrophic cardiac insufficiency 
(20). To model such a system in vivo, we first analyzed the pattern 
of D3 expression in the brain. In sham-operated animals, strong 
D3 immunoreactivity (IR) was detected in the preoptic area, bed 
nucleus of the stria terminalis, and hypothalamus, while moderate 
IR was observed in the cortex and hippocampus, but rather low 
IR was present in the thalamus (Figure 3A). In concordance with 
previous in situ hybridization studies showing strong signals of 
D3 mRNA in neuron-rich layers of the cortex and hippocampus 
(15), the D3 IR appeared in the perikaryon and the apical dendrites 
of the pyramidal cells (Figure 3B) and immunoreactive axons ema-
nating from the strongly immunolabeled areas of the preoptic area 
and the hypothalamus were also visible (Figure 3C). Occlusion of 
the middle cerebral artery (MCAO) resulted in dramatic induction 
of D3 IR in neurons in the ipsilateral somatosensory cortex (Fig-
ure 3E) and hippocampus (Figure 3G).
As these in vivo data confirm the importance of D3 induction in 
ischemic neuronal tissue, we took advantage of the cell coculture 
system characterized here to study the astrocyte-mediated tran-
scriptional T3 footprint under hypoxic conditions, in a chamber 
containing 2% oxygen. Hypoxia was documented by the progressive 
increase in PFK mRNA levels in both cell types (Figure 4A). Under 
these conditions, there was an approximately 6-fold increase in D3 
activity in SK-N-AS cells and a parallel approximately 2-fold increase 
in D2 activity in the H4 cells (Figure 4B). Along with these changes 
in deiodinase expression, the T4-induced EPPN2 gene expression 
in neurons was decreased by approximately 50%, while hypoxia 
alone did not affect basal ENPP2 mRNA levels (Figure 5C) or UCP2 
mRNA (data not shown). D3 expression is upregulated by HIF-1α 
and thus we also used the iron chelator desferrioxamine (DFX), a 
hypoxia mimetic that inhibits HIF ubiquitination and leads to its 
accumulation even under normoxic conditions. Remarkably, expos-
ing the coculture system to 100 μM DFX elicited results very similar 
to hypoxia, i.e., a decrease in TH signaling in SK-N-AS cells, confirm-
ing the involvement of HIF-1α in this pathway (Figure 4, D–F).
In the brain, sonic hedgehog (Shh) protein is expressed in neu-
rons and has been implicated in injury remodeling caused by stroke 
and hypoxia (28). In the setting of our coincubation system, addi-
tion of 4 μg/ml Shh to the coincubation media rapidly increased 
patched (PTC) expression in both cell types, but mainly in SK-N-AS 
cells, indicating that the Shh signaling pathway is active in these 
cells (Figure 5A). Addition of Shh dramatically increased D3 activ-
ity in SK-N-AS cells, while there was progressive loss of D2 activ-
ity in the glial cells (Figure 5B). More importantly, while addition 
of T4 progressively induced neuronal ENPP2 gene expression, the 
Shh-induced changes in deiodinase activity blunted the effect of 
T4 without affecting basal ENPP2 gene expression (Figure 5C) or 
UCP2 expression (Figure 5D). In a reverse strategy, we used cyclo-
pamine, an antagonist of Shh, which progressively decreased PTC 
mRNA levels (Figure 5E) and D3 activity and increased D2 activity 
by approximately 3.5-fold (Figure 5F). Remarkably, cyclopamine 
doubled the effect of T4 on ENNP2 gene expression, increasing it 
from approximately 7- to 15-fold (Figure 5G), whereas only minor 
changes in UCP2 expression were observed (Figure 5H).
LPS-induced inflammation amplifies the astrocyte-mediated neuronal 
transcriptional T3 footprint in a model of central hypothyroidism. At the 
same time, we looked at physiological and/or pathophysiological 
models in which changes in deiodinase expression could increase 
TH signaling. For example, it is known that in rats, the i.p. adminis-
tration of LPS induces D2 expression in tanycytes that is associated 
with suppression of TRH expression and central hypothyroidism, 
Figure 3
Hypoxia induces D3 in the brain and decreases TH signaling. D3 IR using 
the NBP1-5767 α-D3 antiserum in coronal brain sections of male rat 
stroke model: (A–C) sham operated; (D–I) unilateral MCAO for 1 hour. 
(A) Low-power micrograph of a coronal brain section (bregma, –3.3 mm) 
shows widespread distribution of D3 IR in sham. The intensity of D3 
staining exhibits regional variations; in the cerebral cortex and hip-
pocampus of sham-operated controls, the IR is moderate and local-
ized primarily to the apical dendrite (arrowheads) and the perikaryon 
(arrows) of pyramidal cells (B), whereas it is intense in the axons 
(arrowheads) and cell bodies of the hypothalamic preoptic area (C). 
(D–E) Ischemia resulted in an increased D3 IR on the ipsilateral side 
(MCAO-il) compared with the control contralateral side (MCAO-cl) of 
the occlusion shown for both the primary somatosensory cortex (E ver-
sus D) and the hippocampus (G versus F). (H–I) Preincubation of the 
primary antibody with the peptide antigen (PEP) used for immunization 
resulted in complete loss of immunostaining demonstrated in neighbor-
ing hypothalamic sections. Scale bars: 3 mm (A); 50 μm (B); 100 μm 
(C); 1 mm (D–I). DG, dentate gyrus; POA, preoptic area; S1, primary 
somatosensory cortex; V, third ventricle.
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mimicking the situation found in nonthyroidal illness (18). This 
would indicate that an increase in D2 activity in the tanycytes aug-
ments local T3 concentration, negatively regulating TRH expres-
sion in discrete neurons of the hypothalamic PVN. To determine 
the extent to which D2 is involved in such a mechanism, we first 
analyzed PVN TRH mRNA levels in WT and D2-KO mice 12–24 
hours after the systemic administration of LPS (Figure 6). While 
an expected reduction of over 50% in TRH mRNA was observed in 
the WT animals following LPS (Figure 6, A, B, and E), the D2-KO 
animals failed to reduce TRH mRNA levels (Figure 6, C–E). This 
confirms that D2 is a critical component of this pathway.
Currently there are no tanycyte (cell) models that provide suf-
ficiently high cell purity for studies such as these. Thus, to model 
the interrelationship between these cells and TRH-expressing 
neurons in the PVN, we coincubated neuronal SK-N-AS cells 
with H4 glioma cells, which share a similar glial origin with 
tanycytes. The ENPP2 responsiveness to T4 was then tested after 
the addition of LPS. To ensure that the timing and concentra-
tion dependence of the LPS effects was compatible with the cell 
model developed in the present studies, we used HEK-TLR4-
MD2-ELAM cells, which have functional LPS–NF-κB signaling 
via stable expression of the TLR4 receptor and an NF-κB–respon-
sive Luciferase reporter (29). In these cells, addition of 1 μg/ml 
LPS to the media resulted in several-fold activation of the Luc 
reporter gene (Figure 6F) by 6 hours. When used at the same con-
centrations in the coincubation cell system, LPS triggered major 
changes in deiodinase expression, as documented by the approxi-
mately 3-fold increase in D2 mRNA/activity and approximately 
30% decrease in D3 mRNA and activity (Figure 6, G–H). Conse-
quently, there was a dramatic increase in T4-mediated induction 
of neuronal ENPP2 gene expression (Figure 6I), whereas UCP2 
mRNA remained largely unaffected (Figure 6J).
Discussion
These present studies give exciting insights, which we believe are 
new, into how deiodinases regulate TH action in the brain during 
health or disease, providing direct evidence for a unique paradigm 
of TH action. Three steps characterize this paracrine mechanism: 
first, the prohormone T4 is activated in glial cells (astrocytes and 
tanycytes) via D2; next, the resultant T3 exits the glial compartment 
and enters adjacent neurons; and finally, the T3 establishes a tran-
scriptional footprint via binding to neuronal TRs (Figure 7). The 
physiologic implications are considerable, since the generation of 
T3 and its translocation are both potential control points for TH 
signaling in the brain. It is remarkable that the magnitude of the 
glial D2–mediated T3 footprint in neurons is not constant; on the 
contrary, it can be modulated by coordinated changes in D2 and D3 
activities, amplifying or minimizing the TH signaling depending on 
whether the changes favor TH activation (via D2) or inactivation 
(via D3) via the actions of key developmental and/or metabolic mol-
ecules such as hedgehog proteins, HIF-1α, and LPS.
That deiodinases in glial cells and neurons can affect TH signal-
ing was proposed based on their anatomical distribution and on 
the role that deiodinases play in other cell systems such as brown 
adipose tissue and pituitary gland (2). The present findings pro-
vide a mechanistic explanation for how this happens, unequivo-
cally demonstrating that enough D2-generated T3 acts in a para-
crine fashion, establishing a transcriptional footprint in neuronal 
Figure 4
Hypoxia decreases astrocyte-mediated thyroid hormone signaling in neuronal SK-N-AS cells. (A) The coculture system described in Figure 2 
was placed in a hypoxia chamber (1% O2) for the indicated times in the presence of 20 pM T4 (free fraction). Cells were harvested at the indi-
cated times and processed for deiodinase activity or quantitative RT-PCR. PFK, phosphofructokinase. (B) Time course of D2 and D3 activities 
after hypoxia was initiated. (C) ENPP2 mRNA levels in SK-N-AS cells at the indicated time points. (D–F) Same as in A–C, except that cells were 
treated with DFX for the indicated times. Values are mean ± SEM of 6–9 independent wells; *P < 0.01 versus control.
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cells (Figure 2). Of note, enough T3 is produced so that it bypasses 
the inactivating deiodinase (D3) present in neuronal cells. The 
significance of these findings is enhanced because the present 
experiments were performed with physiological amounts of free 
T4, i.e., 20 pM. Addition of T4 to the coculture system was enough 
to change the expression of the T3-responsive gene, ENPP2, only 
in the presence of the D2-expressing H4 glioma cell line. This T4-
dependent effect is blocked by rT3, a D2 inhibitor, and also by the 
highly specific α-T3 antiserum, confirming that D2-generated T3 
is a critical step in this pathway (Figure 2).
Of course, the limitations of our coculture system require one 
to exercise caution when generalizing the results obtained to the 
physiology of the brain. In order to demonstrate the paracrine 
loop connecting neurons and glia (Figure 7), we deconstructed 
the brain’s architecture, purposely keeping these 2 cell types physi-
cally separated (Transwell System). The in vivo situation is likely 
to be more complex, since these cell types (glia and neurons) are 
adjacent and physically touch each other, raising the possibility 
of even more direct local control of TH signaling than seen in our 
studies. Nevertheless, given the known coexpression of D2 and D3 
in the cortex, hippocampus, and hypothalamus (14, 15, 23, 30), 
it is likely that such a mechanism is fully active in these regions; 
the dependency of the LPS-mediated induction of neuronal TRH 
mRNA expression on tanycyte (glial) D2 activity strongly supports 
this hypothesis (Figure 6).
Hypoxia is an important disease signal in the brain, and in the 
present investigation we detected dramatic D3 induction in the 
rat brain after ischemia caused by MCAO (Figure 3). Accord-
ing to the model of TH action in the brain being developed 
here, such a D3 induction would rapidly limit the T3 footprint 
established in neurons, essentially rendering D3-expressing 
neurons relatively hypothyroid. Thus, we took advantage of the 
coculture system to test this hypothesis and found that, indeed, 
hypoxia induces D3 expression approximately 7-fold and lim-
its the astrocyte-dependent T3 footprint in neurons by at least 
50% (Figure 4). Notably, the hypoxic-mimetic agent DFX pro-
Figure 5
Shh signaling limits the H4 astrocyte–mediated mRNA footprint in neuronal SK-N-AS cells. The coculture system described in Figure 2 was 
exposed to Shh for the indicated times in the presence of 20 pM T4 (free fraction). Cells were harvested at the indicated times and processed 
for deiodinase activity or quantitative RT-PCR. (A) Time course of PTC expression after addition of Shh. (B) Time course of D2 and D3 activities 
after addition of Shh. (C) ENPP2 mRNA levels in SK-N-AS cells at the indicated time points. (D) UCP2 mRNA levels in SK-N-AS cells at the indi-
cated time points. (E–H) Same as in A–D, except that cells were treated with 10 μM cyclopamine for the indicated times. Values are mean ± SEM 
of 6–9 independent wells; *P < 0.01 versus control.
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duced similar effects (Figure 4). These data reveal a mechanism 
that is intuitively adaptive in nature, given that D3-mediated 
hypothyroidism would decrease energy expenditure and the O2 
demand of the neurons (20). From a broader perspective, such 
a D3 induction is likely to be part of the injury-healing process 
as observed in other tissues such as the myocardium (31), skel-
etal muscle (32), nerves (33), skin (34), and liver (35). T3 has a 
suppressive effect on the cyclin D1 gene (36), and thus it has 
been hypothesized that a decrease in TH signaling favors cell 
proliferation, which contributes to the healing process. Such a 
mechanism has been linked to cell proliferation in the chicken 
developing growth plate (21), the regenerating liver (35), and 
growth of basal cell carcinoma (22). That this also happens in 
the injured brain is remarkable and indicates that promoting 
spatial-specific hypothyroidism via induction of D3 is a default 
mechanism common to many injured tissues. In addition, the 
Figure 6
LPS signaling amplifies the astrocyte-mediated mRNA footprint in neuronal cells. Effect of LPS on TRH mRNA in the PVN of WT and D2-KO 
mice. Note apparent reduction in TRH mRNA in WT mice following the systemic administration of LPS (A–B), but absence of a response in 
D2-KO animals (C–D). Scale bar: 100 μm. III, third ventricle. (E) Quantification of the TRH mRNA hybridization signal from each of the 4 animal 
groups (n = 4 per group). (F) Luciferase activity in HEK-TLR4-MD2-ELAM cells, which have a functional LPS–NF-κB signaling via stable expres-
sion of the TLR4 receptor and an NF-κB–responsive Luciferase reporter after the addition of 1 μg/ml LPS (bacterial lipopolysaccharide). (G) 
The coculture system described in Figure 2 was exposed to LPS as in F for the indicated times in the presence of 20 pM T4 (free fraction). Cells 
were harvested at the indicated times and processed for deiodinase activity or quantitative RT-PCR. Shown are the time courses of D2 and D3 
mRNA levels or activities (H) after addition of LPS. (I) ENPP2 mRNA levels in SK-N-AS cells at the indicated time points. (J) UCP2 mRNA levels 
in SK-N-AS cells at the indicated time points. Values are mean ± SEM of 6–9 independent wells; *P < 0.01 versus control.
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possibility that D3 induction also plays a role in other types of 
brain injuries is very exciting, as it potentially opens new strate-
gies for approaching patients with diverse neurological disease.
Hedgehog signaling is a known developmental player and is 
also induced by pathophysiological stimuli such as acute brain 
injury and inflammation (37). Addition of Shh in the coculture 
system decreased TH signaling dramatically via induction of D3 
and suppression of D2 activity in astrocytes, which are known 
to respond to Shh signals (ref. 38 and Figure 5). Shh decreased 
the astrocyte-dependent T3 footprint in neurons, while cyclopa-
mine, a Shh antagonist, caused the opposite effect (Figure 5). The 
observation that Shh and TH pathways may be integrated in the 
brain through region-specific distribution of their signaling mol-
ecules (39) should have an impact on our understanding of brain 
development and responsiveness to physiological and patho-
physiological stimuli. In fact, during development, Shh promotes 
proliferation and inhibits differentiation of neural progenitors 
and supports dorso-ventral patterning of the CNS (40, 41). Given 
the critical impact of TH on brain development and function, the 
present investigation suggests that at least some of the Shh effects 
could be mediated through changes in TH signaling. Important-
ly, neural stem cells also exist in the adult nervous systems of all 
mammals and their proliferation is under Shh control (41). Here 
also TH signaling could be involved, explaining its role in higher 
cognitive functions; it has been suggested that Shh-mediated 
adult neurogenesis in the hippocampal dentate gyrus could play 
a role in memory formation (42).
The present studies also provide evidence that changes in deio-
dinase expression can substantially amplify the T3 footprint estab-
lished in neurons via T4 deiodination in astrocytes. Specifically in 
the MBH, D2 is expressed in specialized glial cells, called tanycytes. 
It is known that systemic administration of LPS results in a rapid 
induction of D2 expression and activity in tanycytes, an effect 
linked to the suppression of TRH expression in PVN neurons 
observed in fasting and disease states (18). The observation that 
TRH mRNA in the PVN did not fall in the D2-KO mouse following 
the systemic administration of LPS suggests that D2 activation is a 
critical step in this pathway, supporting a paracrine effect of tany-
cyte-produced T3 via T4 deiodination on hypophysiotropic TRH 
neuronal regulation (Figure 6). To determine whether this was 
possible, we used the cocultured system and found that, indeed, 
exposure to LPS induced D2 expression and activity by 3- to 4-fold 
and more than doubled TH signaling to neurons in this system 
(Figure 6), while not affecting UCP2 mRNA levels.
Refining this paracrine model of TH action will certainly require 
additional studies, in particular directed to understanding the 
behavior of the transporters such as MCT8 in response to the fac-
tors identified as modulating deiodinase activity in the CNS. Addi-
Figure 7
Proposed model of TH signaling in the brain. 3 steps characterize this paracrine mechanism: first, the prohormone T4 is activated in glial cells 
(astrocytes and tanycytes) via D2; next, the resultant T3 exits the glial compartment and enters adjacent neurons; and finally the T3 establishes 
a transcriptional footprint via binding to neuronal TRs. TH transport is via the MCT8 transporter; other TH transporters, e.g., OATP1C1, are 
also known to operate in the brain; LPS activates D2 transcription and Shh promotes D2 inactivation via WSB-1–mediated ubiquitination; both 
hypoxia and Shh activate D3 gene transcription.
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tional molecules and pathways capable of modulating deiodinase 
activity do exist, such as xenobiotic compounds (43), insulin and 
thiazolidinediones (44), and bile acids (45). It is exciting to specu-
late that these and perhaps other still-unidentified signals might 
affect TH action in the brain, with significant implications for 
clinical conditions such as depression and mood disorders, which 
are known to be affected by TH.
Methods
Reagents. T4, T3, forskolin, cyclopamine, FBS, ampicillin, gentamicin, and 
sodium selenite were purchased from Sigma-Aldrich. rT3 was purchased 
from Calbiochem. SK-N-AS cells were provided by S. Huang (Children’s 
Hospital, Boston, Massachusetts, USA), H4 glioma cells were provided by 
M. LaVoie (Brigham and Women’s Hospital), and HEK-TLR4-MD2-Elam 
cells were provided by M. Genest (Eisai Research Institute, Andover, Massa-
chusetts, USA). The Transwell Insert was obtained from Corning Scientific. 
DMEM was purchased from Gibco. All reverse transcriptase materials, 
DNAse, RNAse out, DNTp mix, EDTA, SuperScript II, and DAPI and anti-
bodies, anti-tubulin (mouse), Alexa Fluor 594–conjugated goat anti-mouse 
IgG, and Trizol were purchased from Invitrogen.
Animals. Adult male C57BL/6 WT or D2-KO mice and Sprague-Dawley 
rats were used as detailed in the sections describing the LPS infection and 
hypoxia animal models. The animals were housed under standard environ-
mental conditions (light between 0600–1800 hours, temperature 22 ± 1°C, 
rat chow and water available ad libitum). Animals were kept and experiments 
were performed according to protocols approved by the Animal Care and 
Use Committees of Tufts University and University of Miami in compliance 
with NIH standards. Animal protocols followed the European Communities 
Council Directive of November 24, 1986 (86/609/EEC) and, when appropri-
ate, were reviewed and approved by the Animal Welfare Committee at the 
Institute of Experimental Medicine, Hungarian Academy of Sciences.
LPS infection model. Experiments were performed on male C57BL/6 WT 
or D2-KO mice (C57BL/6 background; Jackson Laboratories) weighing 
between 20 and 30 g. The D2-KO animals have been extensively charac-
terized previously (46). LPS treatment was performed as described (18) 
using 250 μg/100 g of body weight i.p. injection of bacterial LPS (O127:
B8; Sigma-Aldrich) in saline. Twelve or 24 hours after treatment, mice were 
euthanized with an overdose of pentobarbital and perfused through the 
ascending aorta with 4% PFA in 0.1 M PBS-saline. Brains were postfixed 
for 4 hours in the same fixative, cryoprotected in 30% sucrose, and then 
processed for in situ hybridization for TRH as previously described (47).
Brain hypoxia caused by surgical MCAO. Cerebral ischemia in rats was 
induced (n = 10) by a transient 60-minute right MCAO under Nembutal 
anesthesia (60 mg/kg i.p.), as previously described (48, 49). Sham-operated 
animals (n = 10) underwent the same surgical procedure, but no filament 
was advanced to the internal carotid artery. Intraischemic neurological def-
icit was confirmed by detecting gait abnormalities characterized by circling 
or moving to the left in animals with successful MCAO. Animals showing 
no deficits were excluded from the study. After 60 minutes of ischemia, 
animals were perfused with 4% PFA solution in 0.1 M PBS-saline.
Tissue culture and Transwell System. SK-N-AS and H4 were propagated in 
DMEM media with 10% FBS with 15 μg gentamicin and 50 μg ampicillin 
per liter of media. Cells were incubated overnight with 10% charcoal-stripped 
serum the night prior to the treatment with T4 or T3. Media for all cell types 
was supplemented with 10–7 M sodium selenite. Cells were incubated in 
hypoxic or normoxic conditions in closed hypoxia chambers (Billups-Rothen-
berg Inc.). For the Transwell System, 1.5 × 106 H4 cells were plated inside each 
Transwell insert, and 7.5 × 105 SK-N-AS cells were placed a the bottom of the 
6-well plate (Figure 1). Cells were plated on different 6-well plates to avoid 
cell mixture and placed together on the next day with 10% charcoal-stripped 
media. The HEK-TLR4-MD2-Elam cells stably express the TLR4-MD2 com-
plex. These cells were used to establish concentration and timing of the cellu-
lar responsiveness to LPS (29). The cultures were maintained in DMEM media 
with 10% FBS supplemented with 150 μg/ml Zeocin, 300 μg/ml G418, and 
50 μg/ml hygromycin. The cells were treated in triplicate for 2 hours and 
5 hours with 1 μg/ml LPS (026:B6; Sigma-Aldrich) or PBS as control. Mouse 
cortical primary astrocytes were isolated as described (50, 51) and kept in 
MEM supplemented with 10% FCS for 3–4 weeks with 1 passage. As indicated, 
a high-affinity rabbit polyclonal α-T3 antiserum was added to the medium 
at 1:5,000 to trap released T3; when appropriate, equal amounts of normal 
rabbit serum was added to control wells. For immunofluorescence studies, 
SK-N-AS and H4 cells were plated at a lower confluence in 35-mm glass-bot-
tom plates (MatTek Corp.), and after 24 hours, fixation was performed with 
10% formalin in PBS for 30 minutes; cells were then washed in glycine buffer 
(100 mM glycine, pH 7.4), permeabilized with 0.1% Triton X-100 in PBS for 
10 minutes, and incubated overnight with primary α-tubulin (Sigma-
Aldrich). Secondary antibody was α-mouse IgG labeled with Alexa Fluor 594 
(goat; Molecular Probes, Invitrogen). Samples were cured for 24 hours and 
visualized with a Zeiss LSM META 510 (Carl Zeiss) confocal microscope.
Iodothyronine chromatography using UPLC. Cell cultures were incubated with 
about 250,000 cpm of 125I-T4/ml or 125I-T3/ml, totaling 2 ml per well. 
Total free iodothyronine concentration was 20 pM. At the indicated times 
(24 hours), 100 μl of medium was sampled, mixed with 100 μl of 100% 
METOH, and loaded to an AcQuity UPLC System (Waters). Fractions were 
automatically processed through a Flow Scintillation Analyzer Radiomatic 
610TR (PerkinElmer) for radiometry.
RT-PCR. Total RNA was extracted using the Trizol method. Reverse tran-
scriptase was performed using 3.0 μg of total RNA in the SuperScript First-
Strand Synthesis System. Quantitative real-time PCR was performed using 
IQ SYBR Green PCR kit (Bio-Rad) using primers designed for specific genes 
using Primer3 software (v. 0.4.0). Expression of cyclophilin A was used as 
a housekeeping gene. The primer sequences used were as follows: hCycloA 
(forward: GGCAAATGCTGGACCCAACAC, reverse: TGCCATTCCTG-
GACCCAAAGC), hENPP2 (forward: ACTCCGTGAAGGCAAAGAGA, 
reverse: CAAGATCCGGAGATGTTGGT), hMCT8 (forward: AGCTT-
GATCTTATCCCCCAG, reverse: CTGCGCTACTTCACCTACGG), hMCT10 
(forward: GTGCCTCATCATGGGTCTCT, reverse: ACGAAGTAACCCTG-
CAATGG), hOATP14 (forward: AGAGGCCAGGAAGAAAGAGG, reverse: 
TGGACCACACACCACAGACT), hRC3 (forward: TCAAAGTTCCCGAG-
GAGAGA, reverse: CTAAAAGGGCACGGACTCAG), hTRα1 (forward: 
GGCTGTGCTGCTAATGTCAA, reverse: CGGAGGTCAGTCACCTTCAT), 
hTRβ (forward: AGCTGAAAAATGGGGGTCTT, reverse: TCACGTGGT-
GTTTTCGGTAA), and hUCP2 (forward: TCTTTCCCCACCTCTTCCTT, 
reverse: AGGACGAAGATTCTGGCTGA). The PCR cycle conditions were 
as follows: 2 minutes, 30 seconds at 95°C, 30 seconds at 95°C, 30 seconds 
at 60°C, and 45 seconds at 72°C for 50 cycles followed by the melting curve 
protocol to verify the specificity of amplicon generation. Gene expression 
was determined by generation of a standard curve as described (52). cDNA 
synthesis for semiquantitative RT-PCR on 2 separate cultures of cortical 
astrocytes was performed using standard procedures. In the minus reverse 
transcription controls, reverse transcriptase was replaced by water. The 
cDNA was amplified by Taq polymerase for 35 cycles using intron-span-
ning primers. In negative controls, Taq was replaced by water.
D3 immunohistochemistry. Brains were post-fixed in 4% PFA overnight then 
infiltrated with 20% sucrose solution until they sunk. Prior to cutting, brains 
were labeled by micropunches for subsequent identification. 25-μm–thick 
sections were cut on a freezing microtome. Every sixth section per brain from 
operated (MCAO) and sham-operated animals was processed in the same 
staining jars according to immunocytochemical procedures described earlier 
(53). Sections were incubated in 1 μg/ml rabbit polyclonal anti-rat D3 anti-
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serum (NBP1-05767B raised against rat protein residues within aa 250–300; 
Novus Biologicals) for 36 hours at 4°C, followed by biotinylated donkey 
anti-rabbit secondary antibody (1:1,000; Jackson Immunoresearch Labora-
tories) for 2 hours, and finally, peroxidase-conjugated avidin biotin complex 
(ABC, 1:3,000; Vector Laboratories) for 1.5 hours. Tissues were rinsed in PBS 
between immunohistochemical steps. The immunoreactive sites were visual-
ized with 2.5% 3,3-diaminobenzidine and 0.15% nickel ammonium sulfate 
dissolved in TRIS buffer, pH 7.6. In some sections, the immunoreaction 
product was silver-gold intensified (53). Sections were then mounted, dehy-
drated, cleared in xylene, and coverslipped with DPX (Fluka).
The staining pattern obtained by the NBP1-05767B antiserum was compa-
rable to that obtained with an antiserum (NB110-96414 Novus Biologicals) 
recognizing a different epitope of the D3 protein within aa 1–100 (not shown) 
and to in situ hybridization signal for the rat D3 mRNA (23). When increasing 
dilution of the antibody was used, the immunohistochemical signal decreased 
in each D3-positive site in the forebrain. No signal was detected when the pri-
mary antibody (NBP1-05767B) was omitted from the immunohistochemical 
procedure or the working dilution of the antiserum was preincubated with its 
blocking peptide (NBP1-0767PEP; Novus Biologicals).
Deiodination assays. Analysis was performed using cell sonicates prepared 
using 0.1 M phosphate and 1 mM EDTA at pH 6.9 with 10 mM dithio-
threitol and 0.25 M sucrose. D1, D2, and D3 assays were performed as 
previously described (20).
Statistics. Comparisons were performed by 2-tailed Student’s t test, and 
multiple comparisons were by ANOVA followed by Student-Neuman-
Keuls test. P < 0.05 was used to reject the null hypothesis.
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